Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene.
暂无分享,去创建一个
[1] U. Schibler,et al. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Wold,et al. Binding properties of replication protein A from human and yeast cells , 1992, Molecular and cellular biology.
[3] G. Bornkamm,et al. Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene , 1987, Molecular and cellular biology.
[4] E. Dickson,et al. Endothelial cell hypoxia associated proteins are cell and stress specific , 1993, Journal of cellular physiology.
[5] Hans R. Schöler,et al. New type of POU domain in germ line-specific protein Oct-4 , 1990, Nature.
[6] M. Hendrix,et al. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. , 1995, Cancer research.
[7] N. Hay,et al. Regulatory elements that modulate expression of human c-myc. , 1987, Genes & development.
[8] F. Bosch,et al. Evidence from transgenic mice that myc regulates hepatic glycolysis , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] W. Schaffner,et al. cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif. , 1993, Nucleic acids research.
[10] A. Patel,et al. myc function and regulation. , 1992, Annual review of biochemistry.
[11] K. Sakimura,et al. Molecular cloning and the nudeotide sequence of cDNA to mRNA for Don-nearonal enolase (αα enolase) of rat brain and liver , 1985 .
[12] G. Sonenshein,et al. Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells , 1986, Molecular and cellular biology.
[13] S. Hedges,et al. Molecular evidence for the origin of birds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Sassone-Corsi,et al. Alternative usage of initiation codons in mRNA encoding the cAMP-responsive-element modulator generates regulators with opposite functions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. D. de Jong,et al. Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein , 1988, The Journal of cell biology.
[16] J. Lélias,et al. Nucleoticle sequences of cDNAs α and γ enolase mRNAs from mouse brain , 1990 .
[17] Jonathan A. Cooper,et al. Three glycolytic enzymes are phosphorylated at tyrosine in cells transformed by Rous sarcoma virus , 1983, Nature.
[18] C. Croce,et al. Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Leder,et al. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in burkitt lymphoma , 1984, Cell.
[20] H. Farber,et al. Non-neuronal Enolase Is an Endothelial Hypoxic Stress Protein (*) , 1995, The Journal of Biological Chemistry.
[21] R. Ray,et al. Cloning and characterization of a human c-myc promoter-binding protein , 1991, Molecular and cellular biology.
[22] N. Segil,et al. Enolase isoenzymes in adult and developing Xenopus laevis and characterization of a cloned enolase sequence. , 1988, The Biochemical journal.
[23] G. Barbieri,et al. Structure of the human gene for α‐enolase , 1990 .
[24] S. Cogoi,et al. Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Ray,et al. Inhibition of human immunodeficiency virus type 1 replication by a cellular transcriptional factor MBP‐1 , 1997, Journal of cellular biochemistry.
[26] D. Chaudhary,et al. The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. , 1995, Biochemistry.
[27] P. Leder,et al. Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[28] Mark Groudine,et al. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.
[29] M. Groudine,et al. Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.
[30] V. Fischetti,et al. α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci* , 1998, The Journal of Biological Chemistry.
[31] A. Prats,et al. Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells , 1996, The Journal of cell biology.
[32] M. Kozak. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.
[33] S. Cory,et al. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. , 1983, The EMBO journal.
[34] R. Sears,et al. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. , 1994, Genes & development.
[35] H. Towle. Metabolic Regulation of Gene Transcription in Mammals (*) , 1995, The Journal of Biological Chemistry.
[36] F. Bosch,et al. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] Jordi Félez,et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.
[38] O. MacDougald,et al. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Ray,et al. Functional Domains of c-myc Promoter Binding Protein 1 Involved in Transcriptional Repression and Cell Growth Regulation , 1999, Molecular and Cellular Biology.
[40] M. Cole. The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.